TGF-BETA GENE EXPRESSION SIGNATURE IN CANCER PROGNOSIS

摘要

The invention provides methods and kits for determining a prognosis of cancer in a subject by providing a sample taken from a subject, determining a TGF-β signature of the sample using high throughput analysis, and comparing the TGF-β signature of the sample with a control. The aberration of the TGF-β signature of the sample as compared to the control indicates a prognosis of aggressively malignant disease or minimally malignant disease.